Advances in cancer therapy has resulted in more cancer survivors, and now quality of life throughout treatment and surviving years is becoming a new focus for the scientific community. There are often unintended toxicities related to cancer therapies, most commonly cardiotoxicities. HESI established the THRIVE program to address quality-of-life research (http://hesithrive.org). HESI THRIVE aims to address the unrealized gap in research to identify and minimize cancer treatments by offering funding for basic science, clinical and translational research.
Available online here.
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.